Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2016

Every FDA drug recall initiated in 2016, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,199 recalls, newest first.

Class II · Moderate risk

Phenobarbital Tablets

Failed Dissolution Specifications: Phenobarbital Tablets have an out of specification for dissolution at the 12 month stability time point

Terminated Dissolution failure West-Ward Pharmaceuticals Corp. NDC 0143-1455-01 D-1045-2017
Class II · Moderate risk

PredniSONE Tablets USP

Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.

Terminated Failed specification West-Ward Pharmaceutical NDC 0054-4741-25 D-0008-2017
Class III · Low risk

Paricalcitol Capsules

Failed Impurities/Degradation Specifications: This repackaged product was recalled by its manufacturer due to failed results for impurities.

Terminated Impurity / degradation Amerisource Health Services NDC 60687-106-25 D-0009-2017
Class III · Low risk

Clonazepam Tablets

Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.

Terminated Impurity / degradation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-882-20 D-0136-2017
Class III · Low risk

Clonazepam Tablets

Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 15 month timepoint.

Terminated Impurity / degradation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-881-20 D-0135-2017
Class III · Low risk

PARICALCITOL Capsules

Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0093-7658-56 D-0111-2017
Class III · Low risk

PARICALCITOL Capsules

Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0093-7657-56 D-0110-2017
Class III · Low risk

PARICALCITOL Capsules

Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0093-7656-56 D-0109-2017

Recalls by year